The Psychiatry 2026 serves as a premier global platform for scientific exchange, professional development, and research-driven dialogue in the field of mental health. The conference brings together leading academicians, clinicians, researchers, and industry professionals from diverse disciplines to foster interdisciplinary collaboration and the advancement of psychiatry and behavioral sciences. Through high-level scientific discussions and knowledge sharing, the conference plays a significant role in promoting innovation, evidence-based practice, and collaborative learning aimed at improving global mental healthcare.
The conference underscores the necessity of comprehensive, inclusive, and culturally sensitive mental health systems. The scientific program will feature keynote presentations, plenary discussions, oral and poster sessions, and multidisciplinary networking platforms, all designed to stimulate in-depth dialogue on advancing research, enhancing clinical outcomes, and shaping sustainable strategies for global mental well-being. This meeting serves as a premier venue for academic excellence, professional collaboration, and the dissemination of innovative perspectives in the rapidly evolving field of mental health sciences.
WHY ATTEND ?
- Gain valuable insights into the latest advancements in psychiatry, behavioral sciences, neuroscience, psychotherapy, and mental health research
- Connect with leading psychiatrists, psychologists, researchers, clinicians, and global mental health advocates
- Explore opportunities for interdisciplinary collaboration, research partnerships, and innovation in mental healthcare
- Learn about emerging therapies, digital mental health solutions, evidence-based practices, and community-based interventions
- Experience Paris a city renowned for its culture, history, intellectual heritage, and inspiring atmosphere for global scientific exchange
WHO SHOULD ATTEND?
- Academic Deans, Directors, and Department Heads
- Professors, Principal Investigators, and Project Leaders
- Psychiatrists, Psychologists, and Mental Health Clinicians
- Postdoctoral Researchers, Fellows, and Scholars
- Early-Career Researchers, Young Scientists, and Graduate Students
- Healthcare Executives, CEOs, and Organizational Leaders
- Industry Professionals in Research, Development, and Innovation
- Marketing, Business Development, and Strategic Partnership Teams
- Experts Seeking Research, Clinical, or Industry Collaborations
- Product Developers and Solution Providers in Mental Health
- Representatives from Professional Associations and Societies
- Funding Agencies, Grant Organizations, and Philanthropic Bodies
VISA ASSISTANCE:
Longdom provides official documents to support your visa application for the International participants for a smooth travel process, including:
- Cover Letter or Invitation Letter
- Abstract Acceptance Letter
- Accommodation Letter (if booked)
SESSION AND TRACKS:
Track 1: Psychiatric Disorders and Clinical Management
This track focuses on the diagnosis, treatment, and management of major psychiatric disorders, including depression, anxiety, bipolar disorder, and schizophrenia. Sessions will cover clinical guidelines, therapeutic interventions, pharmacological advances, and integrative approaches, providing participants with comprehensive insights into improving patient care and outcomes.
Key Topics: Major depressive disorder | Anxiety disorders | Bipolar disorder | Schizophrenia | Clinical psychiatry | DSM-5 | ICD-11 | Pharmacotherapy | Psychotherapy | Integrative psychiatry | Treatment-resistant depression | Comorbid psychiatric conditions | Patient-centered care
Track 2: Air Pollution Control and Atmospheric Chemistry
This track addresses the sources, characteristics, and impacts of air pollutants on mental and physical health. Discussions will include atmospheric reactions, pollutant dispersion, monitoring technologies, emission control strategies, and environmental policies aimed at mitigating air pollution and promoting public health.
Key Topics: Air pollution | Particulate matter (PM2.5) | Particulate matter (PM10) | Atmospheric chemistry | Pollutant dispersion | Environmental toxicology | Air quality monitoring | Emission control | Environmental policy | Neurotoxicity | Public health impact
Track 3: Behavioral Neuroscience
Focused on understanding the neural mechanisms underlying behavior, this track explores cognition, emotional regulation, decision-making, learning, and memory. Sessions include experimental models, neurobiological approaches, and translational research bridging animal studies and human behavior.
Key Topics: Neural circuits | Cognition | Emotional regulation | Decision-making | Learning and memory | Synaptic plasticity | Neurotransmitters | Animal models | Translational neuroscience | Brain-behavior relationship
Track 4: Child and Adolescent Psychiatry
This track highlights mental health issues in children and adolescents, covering developmental disorders, mood and behavioral disorders, early interventions, family-centered therapy, and school-based mental health programs. It emphasizes strategies to identify and manage mental health challenges early for better long-term outcomes.
Key Topics: Developmental disorders | Pediatric mental health | ADHD | Autism spectrum disorder | Adolescent depression | Early intervention | School-based mental health | Family therapy | Behavioral disorders | Child psychology
Track 5: Neurodegenerative Disorders
Focusing on diseases such as Alzheimer’s, Parkinson’s, and Huntington’s, this track examines the pathophysiology, early diagnosis, clinical management, and emerging therapeutic strategies. It emphasizes translational research, biomarker discovery, and innovative interventions to slow disease progression.
Key Topics: Alzheimer’s disease | Parkinson’s disease | Huntington’s disease | Neurodegeneration | Cognitive decline | Biomarkers | Neuroprotection | Disease-modifying therapies | Protein aggregation | Clinical neurology
Track 6: Cognitive Psychology and Brain Function
This track explores cognitive processes including perception, attention, memory, learning, and problem-solving. Sessions cover experimental studies, computational modeling, and clinical applications to understand how cognitive functions are affected in psychiatric and neurological disorders.
Key Topics: Cognitive processes | Perception | Attention | Executive function | Working memory | Problem-solving | Cognitive impairment | Neuropsychology | Computational modeling | Cognitive assessment
Track 7: Addiction Psychiatry
Addressing substance use and behavioral addictions, this track covers the neurobiology, assessment, prevention, and treatment strategies for addictive disorders. Discussions include rehabilitation approaches, relapse prevention, policy considerations, and public health initiatives.
Key Topics: Substance use disorders | Behavioral addiction | Opioid addiction | Alcohol dependence | Dopamine pathways | Relapse prevention | Rehabilitation | Harm reduction | Addiction neuroscience | Public health policy
Track 8: Psychiatric Genetics and Epigenetics
This track explores genetic and epigenetic contributions to mental health disorders. Topics include genome-wide association studies, gene-environment interactions, molecular mechanisms, and the implications of personalized medicine and predictive psychiatry.
Key Topics: Genome associated Psychiatric | Gene-environment interaction | Epigenetic modification | DNA methylation | Psychiatric genomics | Molecular psychiatry | Polygenic risk scores | Personalized medicine
Track 9: Clinical Psychology and Psychotherapy
Focused on evidence-based psychotherapeutic interventions, this track covers cognitive-behavioral therapy, mindfulness, psychodynamic therapy, and integrative approaches. Participants will gain insights into assessment tools, treatment planning, and innovative therapy techniques for diverse patient populations.
Key Topics: Cognitive behavioral therapy | Mindfulness therapy | Psychodynamic therapy | Trauma-focused therapy | Counseling psychology | Therapeutic alliance | Evidence-based practice | Psychological assessment
Track 10: Neuroimaging and Brain Mapping
This track examines advanced neuroimaging techniques such as MRI, fMRI, PET, and EEG, emphasizing their role in understanding brain structure and function. Sessions will include clinical applications, research methodologies, and insights into psychiatric and neurological disorders.
Key Topics: MRI | fMRI | PET scan | EEG | Brain connectivity | Functional imaging | Structural imaging | Brain mapping | Neurodiagnostics | Neuroinformatics
Track 11: Psychopharmacology and Novel Therapeutics
Focused on drug development and clinical applications, this track covers pharmacological interventions for psychiatric and neurological disorders. Discussions include mechanisms of action, clinical trials, novel therapeutics, personalized medicine, and strategies for improving treatment efficacy.
Key Topics: Antidepressants | Antipsychotics | Mood stabilizers | Drug development | Clinical trials | Precision psychiatry | Pharmacogenomics | Novel therapeutics | Ketamine therapy | Neuropharmacology
Track 12: Mental Health Policy and Public Health
This track emphasizes the development and implementation of mental health policies, community-based programs, and public health strategies. Topics include global mental health challenges, healthcare delivery, access to care, preventive interventions, and population-level strategies to improve mental well-being.
Key Topics: Global mental health | Mental health policy | Healthcare access | Community psychiatry | Preventive psychiatry | Epidemiology | Mental health advocacy | Health systems strengthening
Track 13: Sleep Disorders and Circadian Rhythms
Addressing the impact of sleep and circadian rhythms on mental health, this track covers disorders such as insomnia, sleep apnea, and circadian rhythm disturbances. Sessions highlight diagnosis, treatment strategies, neurobiological mechanisms, and the relationship between sleep and psychiatric conditions.
Key Topics: Insomnia | Sleep apnea | Circadian rhythm disorders | REM sleep | Sleep-wake cycle | Chronobiology | Sleep medicine | Psychiatric comorbidity | Melatonin regulation
Track 14: Neurodevelopmental Disorders
This track focuses on conditions such as autism spectrum disorders, ADHD, and intellectual disabilities. Topics include early diagnosis, therapeutic strategies, educational interventions, and research aimed at improving functional outcomes and quality of life for affected individuals.
Key Topics: Autism spectrum disorder | ADHD | Intellectual disability | Developmental delay | Early diagnosis | Behavioral therapy | Neurodevelopmental research | Inclusive education
Track 15: Neuroinflammation and Neuroimmunology
Exploring the role of immune mechanisms in psychiatric and neurological disorders, this track covers neuroinflammation, autoimmune disorders, biomarkers, and therapeutic interventions targeting immune pathways to improve mental health outcomes.
Key Topics: Neuroinflammation | Cytokines | Blood-brain barrier | Autoimmune encephalitis | Neuroimmune interaction | Inflammatory biomarkers | Microglia activation | Immunotherapy
Track 16: Digital Psychiatry and e-Mental Health
This track highlights the integration of digital technologies into mental health care. Topics include telepsychiatry, mobile apps, AI-driven diagnostics, digital therapeutics, remote monitoring, and the ethical, clinical, and research implications of technology in mental health services.
Key Topics: Telepsychiatry | Digital therapeutics | AI in mental health | Mobile health apps | Remote monitoring | Virtual therapy | Health informatics | Machine learning in psychiatry
Track 17: Geriatric Psychiatry and Aging Brain
Focused on the mental health challenges of aging populations, this track addresses dementia, depression, anxiety, and cognitive decline. Sessions emphasize assessment tools, therapeutic interventions, caregiver support, and strategies to maintain mental and cognitive health in older adults.
Key Topics: Dementia | Late-life depression | Cognitive aging | Geriatric assessment | Caregiver burden | Neurocognitive disorders | Aging population | Memory disorders
Track 18: Stress, Trauma, and Resilience
This track examines the biological, psychological, and social aspects of stress and trauma. It covers resilience-building strategies, therapeutic interventions, coping mechanisms, and evidence-based approaches to promote mental well-being and recovery following traumatic experiences.
Key Topics: Post-traumatic stress disorder | Trauma-informed care | Stress response | Resilience training | Coping mechanisms | Psychological recovery | Mental well-being | Psychosocial interventions
MARKET ANALYSIS REPORT:
The global psychiatry and behavioral health market is experiencing robust growth as mental health awareness, diagnosis, and treatment services expand worldwide. In 2025, the behavioral health market—which encompasses psychiatric care, therapy, counseling, and related services—was valued at approximately USD 184.94 billion, and is forecast to reach around USD 197.34 billion in 2026, continuing on a strong growth trajectory toward USD 330.35 billion by 2034 at an estimated CAGR of 6.7%.
Mental health services form a significant portion of global healthcare expenditure, with broader estimates of the global mental health market valued at over USD 410 billion in 2023 and projected to exceed USD 573 billion by 2033. This expansion reflects rising demand for behavioral therapy, outpatient psychiatry, digital mental health platforms, and integrative care pathways.
Additionally, precision psychiatry, focusing on personalized diagnostics and tailored treatments using genetic and biomarker technologies, is forecast to grow from roughly USD 825.6 million in 2024 to about USD 2.86 billion by 2033, with an estimated CAGR of 14.9%.